Showing results (71-80 of 121) with videos related to
Sort By:
Pageof 13
The Oncologist|August 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatmentLi Zhou, Min Cao, Haibin Zhu, et al.Clinical Genitourinary Cancer|April 7, 2022
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell CarcinomaXieqiao Yan, Li Zhou, Siming Li, et al.Cancer Management and Research|May 7, 2025
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral MelanomaJiaran Zhang, Huichun Tian, Lili Mao, et al.Journal of Cancer|April 1, 2020
A Functional Synonymous Variant in PDGFRA Is Associated with Better Survival in Acral MelanomaJie Dai, Lu Yang, Tianxiao Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.European Journal of Cancer (Oxford, England : 1990)|September 22, 2022
Cumulative incidence and risk factors of brain metastasis for acral and mucosal melanoma patients with stages I-IIIYang Wang, Bin Lian, Lu Si, et al.Ebiomedicine|April 27, 2020
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinomaXinan Sheng, Xieqiao Yan, Zhihong Chi, et al.Innovation (Cambridge (Mass.))|June 17, 2024
IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinomaChuanliang Cui, Juan Li, Yue Yang, et al.BMC Cancer|May 20, 2022
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I studyLi Zhou, Xiaowen Wu, Zhihong Chi, et al.Journal of Cancer|February 6, 2019
Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation SequencingJiayi Yu, Xiaowen Wu, Junya Yan, et al.Pageof 13